Skip to content
Biodatica
Start free

Investigator

Chang Liu

UNIVERSITY OF MASSACHUSETTS AMHERST · funded by NIGMS, NIAID

Companies
2

Resolved onto their grants.

Grants
5

Federal awards on file.

Non-dilutive funding
$2.4M

Summed across those awards.

First award
Jan 18, 2023

Latest Jul 1, 2024.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R35

    Rapid Culture-Independent Detection of Sepsis Causing Microorganism Directly from Blood

    $406k

    Jul 1, 2024NIGMSUNIVERSITY OF MASSACHUSETTS AMHERSTNIH RePORTER · 11126801 (opens the source filing in a new tab)

  2. R35

    Rapid Culture-Independent Detection of Sepsis Causing Microorganism Directly from Blood

    $406k

    Jul 1, 2024NIGMSUNIVERSITY OF MASSACHUSETTS AMHERSTNIH RePORTER · 11333835 (opens the source filing in a new tab)

  3. DP2

    Emerging mechanisms of viral gene regulation from battles between host and SARS-CoV-2

    $488k

    Aug 1, 2023NIAIDJOHNS HOPKINS UNIVERSITYNIH RePORTER · 11136265 (opens the source filing in a new tab)

  4. R61

    Nanopore-Based HIV Self-Test for Ultrasensitive p24 Quantification in FingerPrick Blood

    $410k

    Jan 18, 2023NIAIDUNIVERSITY OF MASSACHUSETTS AMHERSTNIH RePORTER · 11236112 (opens the source filing in a new tab)

  5. R33

    Nanopore-Based HIV Self-Test for Ultrasensitive p24 Quantification in FingerPrick Blood

    $673k

    Jan 18, 2023NIAIDUNIVERSITY OF MASSACHUSETTS AMHERSTNIH RePORTER · 11470792 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources